Optonol
Miniature Surgical Implants for Glaucoma Patients
StartupOptonol is a Neve Ilan-based startup in the Health Tech & Life Sciences sector, established in 1996. Miniature Surgical Implants for Glaucoma Patients. The company has raised a total of $30M across 2 funding rounds, currently at the Acquired stage. Optonol was founded by Yaron Ira and Benad Goldwasser. Key investors include Israel HealthCare Ventures, Pitango VC, Avi Fischer, among 5 total investors. The company has 1-10 employees. Core technologies: Materials & Substances, Implants.
With $30M in total funding, Optonol is a Acquired-stage company operating in Health Tech & Life Sciences. The company follows a B2B business model. Product stage: Released. The company holds 1 patent. Optonol has been acquired.
- StageAcquired
- ProductReleased
- ModelB2B
- Employees1-10
- HQNeve Ilan
- DistrictJerusalem District
- StatusAcquired
- Last Round$20M
- Israel HealthCare Ventures
- Pitango VC
- Avi Fischer
5 investors total
Yaron IraCo-founder (No longer with the company)
Benad GoldwasserCo-founder (No longer with the company)
1 article covered by sources including www.globes.co.il.
What does Optonol do?
Optonol's flagship product, Ex-Press, is a miniature surgical implant used to lower intra-ocular pressure in patients with glaucoma. Optonol was founded as a spin-off of Jerusalem-based stent developer Medinol Ltd. Optonol was acquired by Alcon in December 2009. A year later, Alcon was acquired by Novartis.
How much funding has Optonol raised?
Optonol has raised $30M in total funding across 2 rounds. The company is currently at the Acquired stage. Key investors include Israel HealthCare Ventures, Pitango VC, Avi Fischer.
Who founded Optonol?
Optonol was founded in 1996 by Yaron Ira (Co-founder (No longer with the company)), Benad Goldwasser (Co-founder (No longer with the company)).
What sector is Optonol in?
Optonol operates in Health Tech & Life Sciences, Medical Devices, Medical Treatment & Therapeutics, with core technologies in Materials & Substances, Implants. Target customers: Healthcare & Life Sciences, Healthcare, Providers.
Where is Optonol located?
Optonol is based in Neve Ilan, Israel, Jerusalem District.